FluroSat has also received funding from cotton industry-focused public-private partnership CRDC for its remote crop imaging platform.

Qualcomm-backed Practice Fusion has agreed to an acquisition by Allscripts, having once been touted for an IPO that would have valued it at $1.5bn.

Tencent has participated in a nine-digit renminbi round for online musical tuition platform Peilian alongside its existing investors.

The Cambridge genomics spinout has secured $5.4m in additional series A funding from drug maker Taiho Pharmaceutical.

Agent Capital, formed by Ex-Baxalta Ventures managing partner Geeta Vemuri, has raised $52m of a planned $150m for its first fund.

GE Ventures, Kaiser Permanente Ventures and existing backer Illumina Ventures have helped Genome Medical take its total funding to $23m

KBP Biosciences, which is developing drugs for disease areas of unmet need, raised the series A funds from investors including Cash Capital.

Grupo Sura returned to back a $42m series B round for MoneyLion, which has now secured a total of $67m in equity funding.

Oncology drug developer Genetron Health, which closed a Vcanbio-led series B round in 2016, has added $61.6m to its coffers.